Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

T Rowe Price Health Sciences Fd: (MF: PRHSX)

(MF) As of Feb 4, 2016 06:05 PM ET

 Add to portfolio

$59.13 USD

+0.11 (0.19%)

Is PRHSX a
Buy, Hold or Sell?

See its Zacks Rank in our free fund analysis report.

Get Free Report for PRHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Dec 31, 2015

Total Return %* Percentile Rank Objective
YTD 12.98 9
3 months 7.43 61
6 months -6.05 43
1 Year 12.98 9
3 Year 31.17 18
5 Year 27.01 12
10 Year 16.76 3

* Annual for three years and beyond.

Zacks Premium Research for PRHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?]
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 31.66
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 12/31/2015 15,659.00
%Turnover 12/31/2015 29.60

Risk

3 Year 5 Year 10 Year
Beta 0.85 0.90 0.86
Alpha 17.20 14.87 10.00
R Squared 0.37 0.50 0.62
Std. Dev. 14.98 14.89 16.68
Sharpe 2.17 1.90 1.00

Sector / Country Weightings

As of 12/31/2015 % of Portfolio
Health 52.20
Finance 16.70
Other 10.07
Services 8.65
Retail Trade 5.43
Technology 3.66
Industrial Cyclical 2.70
Non-Durable 0.59

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2015)
% of Portfolio Value (Mil$)
ALLERGAN INC 4.97 675.99
ALEXION PHARMACEUTICALS I 3.93 533.92
UNITEDHEALTH GROUP INC 3.81 517.61
HUMANA INC 3.44 467.13
AETNA INC 3.34 453.96
VALEANT PHARMACEUTICALS 3.32 451.80
GILEAD SCIENCES INC 3.04 412.69
CIGNA CORP 2.91 395.74
INCYTE PHARMACEUTICALS IN 2.71 368.83

Stock Holding % of Net Assets

As Of 9/30/2015
Total Issues 151
Avg. P/E 20.75
Avg. P/Book 4.47
Avg. EPS Growth 10.36
Avg. Market Value (Mil $) 39,326

Allocation

% of Portfolio
Large Growth 17.22
Large Value 0.00
Small Growth 26.86
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 28.89
Foreign Bond 0.00
High Yield Bond 0.00